Everything by David.

Investing

Guggenheim Raises Roku Price Target to $130 as Streaming Households Cross 100 Million: Is the Inflection Real?

Apr 22, 2026 Investing

Wall Street Piles Into UnitedHealth: Argus Upgrades to Buy as Three More Firms Raise Targets After Q1 Crushes Expectations

Apr 22, 2026 Investing

Wells Fargo Upgrades Airbnb to Overweight With a $178 Target: Is the Business Inflection Point Finally Here?

Apr 22, 2026 Investing

Avis Climbs 13% as Parabolic Rally Puts an Equity Offering Squarely on the Table

Apr 22, 2026 Investing

SNAP Falls 6% as Post-Rally Profit-Taking Tests the Restructuring Thesis

Apr 21, 2026 Investing

Coinbase Drops 7% as the Decoupling From Bitcoin Signals Clarity Act Fatigue

Apr 21, 2026 Investing

UnitedHealth Surges 9%, Humana Gains 5% as Earnings Strength Eases Medicare Advantage Concerns

Apr 21, 2026 Investing

Hertz Loses 9% as Profit-Takers Exit a Parabolic Rally and Barclays’ Avis Downgrade Roils the Sector

Apr 21, 2026 Investing

Opendoor Climbs 11% on Breakout Hopes: Is the AI-Driven Housing Stack Finally Getting Its Due?

Apr 21, 2026 Investing

FuelCell Energy Jumps 6% on Technology Edge as Plug Power Retreats 5% Before Earnings

Apr 21, 2026 Investing

UBS Hikes Meta Platforms’ Target From $872 to $908: Is the GenAI Ad Revenue Machine Just Warming Up?

Apr 21, 2026 Investing

HSBC Just Upgraded Intel to Buy and Raised the Price Target From $50 to $95: Is the Comeback Real?

Apr 21, 2026 Investing

UBS Raises Alphabet’s Target to $375 as Cloud Strength and TPU Sales Ease ChatGPT Ad Fears

Apr 21, 2026 Investing

UBS Hikes Bloom Energy’s Price Target From $170 to $251 on the 800 VDC Data Center Revolution

Apr 21, 2026 Investing

Wall Street Backs Apple’s Historic CEO Transition: Is the Tim Cook Era Ending a Buying Opportunity?

Apr 21, 2026 Investing

KeyBanc Just Upgraded CrowdStrike to Overweight With a $525 Target: Is Mythos the Next AI Cybersecurity Inflection?

Apr 21, 2026 Investing

RBC Just Lifted Marvell’s Target From $115 to $170 After Amazon’s Blockbuster Anthropic Deal

Apr 21, 2026 Investing

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

Apr 21, 2026 Investing

Berenberg Initiates Palo Alto Networks at Buy: Is AI the Next Inflection for Cybersecurity’s Quality Compounder?

Apr 21, 2026 Investing

UBS Trims Qualcomm’s Target to $150: Why Rising Memory Prices Are Becoming a Chip Stock Headwind

Apr 21, 2026